Yu Xia, Director at Summit Therapeutics Inc. (SMMT), bought 31,523,530 shares at $1.05 ($47.7M) on 2023-03-07, disclosed to the SEC on 2024-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.51 | 10,000,000 | $25.1M | 52.6% |
| 2 | $1.05 | 21,523,530 | $22.6M | 47.4% |
| Total | $1.51 avg | 31,523,530 | $47.7M | 100% |